Loading…
Pharmahealthonline.com was cited for unlawfully selling unapproved and misbranded opioid and benzodiazepine drugs over the internet in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), and 505(a)). The company's website introduced these controlled substances into interstate commerce without FDA approval and without proper labeling, creating significant public health risks given the ongoing opioid epidemic and the high potential for benzodiazepine abuse and polysubstance overdose deaths. The FDA emphasized that unapproved drugs lack the safety and efficacy assurances required for legitimate pharmaceutical products and that easy internet availability of these substances poses severe dangers to U.S. consumers.